SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 88.44 |
| Enterprise Value ($M) | 84.12 |
| Book Value ($M) | 92.85 |
| Book Value / Share | 0.57 |
| Price / Book | 0.95 |
| NCAV ($M) | 40.29 |
| NCAV / Share | 0.25 |
| Price / NCAV | 2.20 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.04 |
| Return on Assets (ROA) | -0.60 |
| Return on Equity (ROE) | -0.70 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 4.22 |
| Current Ratio | 4.22 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 67.38 |
| Assets | 119.94 |
| Liabilities | 27.09 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -115.95 |
| Net Income | -111.13 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -90.50 |
| Cash from Investing | 1.13 |
| Cash from Financing | 47.75 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | Column Group Iii, Lp | 32.00 | 262.62 | |
| 13D/A | Casdin Capital, LLC | 4.30 | 4.76 | |
| 13G/A | Jpmorgan Chase & Co | 2.80 | -55.69 | |
| 13G/A | Ra Capital Management, L.p. | 0.00 | -100.00 | |
| 13G/A | BlackRock, Inc. | 6.70 | 39.87 | |
| 13D/A | Beehouse, LLC | 0.03 | -99.83 | |
| 13G/A | Price T Rowe Associates Inc /md/ | 3.80 | -33.36 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 499,635 | 1,416,134 | 35.28 | |
| 1,032,306 | 2,415,831 | 42.73 | |
| 1,172,710 | 2,929,011 | 40.04 | |
| 679,283 | 1,350,092 | 50.31 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| TECH – Bio-Techne Corporation | TERN – Terns Pharmaceuticals, Inc. |
| TLRY – Tilray Brands, Inc. | TRML – Tourmaline Bio, Inc. |
| TSHA – Taysha Gene Therapies, Inc. |
Financial data and stock pages provided by
Fintel.io